{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:16:00Z","timestamp":1794255360693,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971809"],"award-info":[{"award-number":["81971809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Procedural sedation for diagnostic examination is a common practice in children. The study aims to analyze the sedative effect and safety of intranasal dexmedetomidine combined with oral midazolam in outpatient pediatric procedural sedation across different age groups and to assess the incidence of sedation failure. From February 2021 to September 2021, children who underwent procedural sedation were retrospectively enrolled. The children were divided into 4 groups based on age: the infant group (0 to 1\u00a0year old), toddler group (1 to 3\u00a0years old), preschool group (3 to 6\u00a0years old), and school-age group (6 to 12\u00a0years old). Two-mcg\/kg intranasal dexmedetomidine and 0.5-mg\/kg oral midazolam were used for sedation. The sedation success rate after rescue, sedation success rate, onset time of sedation, and the sedation time were recorded. The incidence of adverse events and the risk factors for sedation failure were also analyzed. A total of 4758 patients were identified. After exclusion, 3149 patients were ultimately enrolled. The combination of 2-mcg\/kg intranasal dexmedetomidine and 0.5-mg\/kg oral midazolam resulted in a total success rate of 99.7% and a sedation success rate of 91.4%. The sedation success rate varied among the four groups: 90.2% in the infant group, 93.1% in the toddler group, 92.7% in the preschool group, and 78.4% in the school-age group. The sedation success rate was significantly lower in the school-age group compared to the other three groups (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The onset time of sedation was shorter in infant (22\u00a0min, IQR: 18\u201328\u00a0min, <jats:italic>P<\/jats:italic> &lt; 0.001) and longer in the school-age group (30\u00a0min, IQR: 25\u201335\u00a0min, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Additionally, the infants had a longer sedation time (110\u00a0min, IQR: 90\u2013135\u00a0min, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and a higher rate of delayed recovery (27.5%, all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The incidence of adverse events was low (4.70%), which bradycardia (2.03%) being the most common. Age (0\u20131\u00a0year and\u2009&gt;\u20096\u00a0years), weight, ASA class II, and history of\u00a0failed sedation were identified as risk factors of sedation failure.<\/jats:p>\n                <jats:p>\u00a0 <jats:italic>Conclusion<\/jats:italic>: Intranasal administration of 2-mcg\/kg dexmedetomidine combined with oral administration of 0.5-mg\/kg midazolam was found to be efficient and safety for pediatric procedural sedation. Different age groups of children exhibited distinct sedation characteristics, and age was identified as a risk factor affecting the efficacy of sedation.\n<jats:table-wrap><jats:table><jats:tbody>\n                      <jats:tr>\n                        <jats:td colspan=\"2\"><jats:bold>What is Known:<\/jats:bold>\u2022 <jats:italic>Procedural sedation for diagnostic examination is a common practice in children.<\/jats:italic>\u2022 <jats:italic>The combination of dexmedetomidine with midazolam can improve sedative effects.<\/jats:italic><\/jats:td>\n                      <\/jats:tr>\n                      <jats:tr>\n                        <jats:td colspan=\"2\"><jats:bold>What is New:<\/jats:bold>\u2022 <jats:italic>The success rate of sedation using a combination of 2-mcg\/kg intranasal dexmedetomidine and 0.5-mg\/kg oral midazolam was significantly lower in school-age children as compared to infants, toddlers, and preschoolers.<\/jats:italic>\u2022 <jats:italic>The onset time of sedation increased with age, and the sedation time was found to be longer in infant patients.<\/jats:italic><\/jats:td>\n                      <\/jats:tr>\n                    <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00431-023-05240-5","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T13:02:54Z","timestamp":1697720574000},"page":"169-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The effect of age on outpatient pediatric procedural sedation with intranasal dexmedetomidine and oral midazolam"],"prefix":"10.1007","volume":"183","author":[{"given":"Xiaqing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiya","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"issue":"3","key":"5240_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/adc.2008.153072","volume":"96","author":"E Starkey","year":"2011","unstructured":"Starkey E, Sammons HM (2011) Sedation for radiological imaging. Arch Dis Child Educ Pract Ed 96(3):101\u2013106","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"5240_CR2","doi-asserted-by":"crossref","unstructured":"Badina L, Norbedo S, Barbi E (2006) Procedural sedation and analgesia in children. Lancet 367(9526):1900\u20131901; author reply 1901","DOI":"10.1016\/S0140-6736(06)68838-7"},{"issue":"3","key":"5240_CR3","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1542\/peds.2005-1445","volume":"117","author":"LC Heistein","year":"2006","unstructured":"Heistein LC, Ramaciotti C, Scott WA, Coursey M, Sheeran PW, Lemler MS (2006) Chloral hydrate sedation for pediatric echocardiography: physiologic responses, adverse events, and risk factors. Pediatrics 117(3):e434\u2013e441","journal-title":"Pediatrics"},{"issue":"6","key":"5240_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12098-013-1298-y","volume":"81","author":"R Fallah","year":"2014","unstructured":"Fallah R, Alaei A, Akhavan Karbasi S, Shajari A (2014) Chloral hydrate, chloral hydrate-promethazine and chloral hydrate-hydroxyzine efficacy in electroencephalography sedation. Indian J Pediatr 81(6):541\u2013546","journal-title":"Indian J Pediatr"},{"issue":"2","key":"5240_CR5","first-page":"72","volume":"23","author":"JL Miller","year":"2018","unstructured":"Miller JL, Capino AC, Thomas A, Couloures K, Johnson PN (2018) Sedation and analgesia using medications delivered via the extravascular route in children undergoing laceration repair. J Pediatr Pharmacol Ther 23(2):72\u201383","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"5240_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1651-2227.2006.00156.x","volume":"96","author":"DA de Gast-Bakker","year":"2007","unstructured":"de Gast-Bakker DA, van der Werff SD, Sibarani-Ponsen R, Swart EL, Plotz FB (2007) Age is of influence on midazolam requirements in a paediatric intensive care unit. Acta Paediatr 96(3):414\u2013417","journal-title":"Acta Paediatr"},{"issue":"1","key":"5240_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jclinane.2009.02.016","volume":"22","author":"SD Bergese","year":"2010","unstructured":"Bergese SD, Patrick Bender S, McSweeney TD, Fernandez S, Dzwonczyk R, Sage K (2010) A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. J Clin Anesth 22(1):35\u201340","journal-title":"J Clin Anesth"},{"issue":"4","key":"5240_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1460-9592.2010.03279.x","volume":"20","author":"K Jain","year":"2010","unstructured":"Jain K, Ghai B, Saxena AK, Saini D, Khandelwal N (2010) Efficacy of two oral premedicants: midazolam or a low-dose combination of midazolam-ketamine for reducing stress during intravenous cannulation in children undergoing CT imaging. Paediatr Anaesth 20(4):330\u2013337","journal-title":"Paediatr Anaesth"},{"issue":"5","key":"5240_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1213\/ANE.0b013e31822b8629","volume":"113","author":"KP Mason","year":"2011","unstructured":"Mason KP, Lerman J (2011) Review article: dexmedetomidine in children: current knowledge and future applications. Anesth Analg 113(5):1129\u20131142","journal-title":"Anesth Analg"},{"key":"5240_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jclinane.2017.01.014","volume":"38","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Shin WJ, Park S, Ahn HS, Oh JH (2017) The sedative effects of the intranasal administration of dexmedetomidine in children undergoing surgeries compared to other sedation methods: a systematic review and meta-analysis. J Clin Anesth 38:33\u201339","journal-title":"J Clin Anesth"},{"issue":"8","key":"5240_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/pan.12408","volume":"24","author":"J Wu","year":"2014","unstructured":"Wu J, Mahmoud M, Schmitt M, Hossain M, Kurth D (2014) Comparison of propofol and dexmedetomidine techniques in children undergoing magnetic resonance imaging. Paediatr Anaesth 24(8):813\u2013818","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"5240_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/PEC.0000000000001199","volume":"36","author":"C Sulton","year":"2020","unstructured":"Sulton C, Kamat P, Mallory M, Reynolds J (2020) The use of intranasal dexmedetomidine and midazolam for sedated magnetic resonance imaging in children: a report from the pediatric sedation research consortium. Pediatr Emerg Care 36(3):138\u2013142","journal-title":"Pediatr Emerg Care"},{"issue":"9","key":"5240_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/pan.13202","volume":"27","author":"G Cozzi","year":"2017","unstructured":"Cozzi G, Monasta L, Maximova N, Poropat F, Magnolato A, Sbisa E, Norbedo S, Sternissa G, Zanon D, Barbi E (2017) Combination of intranasal dexmedetomidine and oral midazolam as sedation for pediatric MRI. Paediatr Anaesth 27(9):976\u2013977","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"5240_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/pan.14307","volume":"32","author":"E Inserra","year":"2022","unstructured":"Inserra E, Colella U, Caredda E, Diplomatico M, Puzone S, Moschella S, Capristo C, Tedeschi G, Caranci F, Cirillo M, Miraglia Del Giudice E, Montaldo P (2022) Safety and effectiveness of intranasal dexmedetomidine together with midazolam for sedation in neonatal MRI. Paediatr Anaesth 32(1):79\u201381","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"5240_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.12701\/yujm.2020.00171","volume":"37","author":"SM Jung","year":"2020","unstructured":"Jung SM (2020) Drug selection for sedation and general anesthesia in children undergoing ambulatory magnetic resonance imaging. Yeungnam Univ J Med 37(3):159\u2013168","journal-title":"Yeungnam Univ J Med"},{"issue":"1","key":"5240_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/archdischild-2013-305720","volume":"100","author":"MI Altamimi","year":"2015","unstructured":"Altamimi MI, Sammons H, Choonara I (2015) Inter-individual variation in midazolam clearance in children. Arch Dis Child 100(1):95\u2013100","journal-title":"Arch Dis Child"},{"issue":"1","key":"5240_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13052-021-01196-0","volume":"48","author":"F Cossovel","year":"2022","unstructured":"Cossovel F, Trombetta A, Ramondo A, Riccio G, Ronfani L, Saccari A, Cozzi G, Barbi E (2022) Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam. Ital J Pediatr 48(1):5","journal-title":"Ital J Pediatr"},{"issue":"6","key":"5240_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1046\/j.1365-2125.2003.01944.x","volume":"56","author":"M Anttila","year":"2003","unstructured":"Anttila M, Penttila J, Helminen A, Vuorilehto L, Scheinin H (2003) Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 56(6):691\u2013693","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"5240_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1213\/ANE.0000000000004264","volume":"130","author":"P Uusalo","year":"2020","unstructured":"Uusalo P, Guillaume S, Siren S, Manner T, Vilo S, Scheinin M, Saari TI (2020) Pharmacokinetics and sedative effects of intranasal dexmedetomidine in ambulatory pediatric patients. Anesth Analg 130(4):949\u2013957","journal-title":"Anesth Analg"},{"issue":"1","key":"5240_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4097\/kjae.2013.65.1.9","volume":"65","author":"YH Shin","year":"2013","unstructured":"Shin YH, Kim MH, Lee JJ, Choi SJ, Gwak MS, Lee AR, Park MN, Joo HS, Choi JH (2013) The effect of midazolam dose and age on the paradoxical midazolam reaction in Korean pediatric patients. Korean J Anesthesiol 65(1):9\u201313","journal-title":"Korean J Anesthesiol"},{"issue":"9","key":"5240_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1592\/phco.24.13.1177.38089","volume":"24","author":"CE Mancuso","year":"2004","unstructured":"Mancuso CE, Tanzi MG, Gabay M (2004) Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 24(9):1177\u20131185","journal-title":"Pharmacotherapy"},{"key":"5240_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.889369","volume":"10","author":"BL Li","year":"2022","unstructured":"Li BL, Luo H, Huang JX, Zhang HH, Paquin JR, Yuen VM, Song XR (2022) Using intranasal dexmedetomidine with buccal midazolam for magnetic resonance imaging sedation in children: a single-arm prospective interventional study. Front Pediatr 10:889369","journal-title":"Front Pediatr"},{"key":"5240_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3389\/fphar.2019.00756","volume":"10","author":"CY Wang","year":"2019","unstructured":"Wang CY, Ihmsen H, Hu ZY, Chen J, Ye XF, Chen F, Lu Y, Schuttler J, Lian QQ, Liu HC (2019) Pharmacokinetics of intranasally administered dexmedetomidine in Chinese children. Front Pharmacol 10:756","journal-title":"Front Pharmacol"},{"issue":"2","key":"5240_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/ALN.0000000000004258","volume":"137","author":"BL Li","year":"2022","unstructured":"Li BL, Guan YP, Yuen VM, Wei W, Huang M, Zhang MZ, Li AW, Standing JF, Zhong GP, Song XR (2022) Population pharmacokinetics of intranasal dexmedetomidine in infants and young children. Anesthesiology 137(2):163\u2013175","journal-title":"Anesthesiology"},{"issue":"26","key":"5240_CR25","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/S0024-3205(97)01011-4","volume":"61","author":"T Tateishi","year":"1997","unstructured":"Tateishi T, Nakura H, Asoh M, Watanabe M, Tanaka M, Kumai T, Takashima S, Imaoka S, Funae Y, Yabusaki Y, Kamataki T, Kobayashi S (1997) A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sci 61(26):2567\u20132574","journal-title":"Life Sci"},{"issue":"1","key":"5240_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/106002809603000104","volume":"30","author":"J Hughes","year":"1996","unstructured":"Hughes J, Gill AM, Mulhearn H, Powell E, Choonara I (1996) Steady-state plasma concentrations of midazolam in critically ill infants and children. Ann Pharmacother 30(1):27\u201330","journal-title":"Ann Pharmacother"},{"issue":"4","key":"5240_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40272-022-00511-4","volume":"24","author":"Y Cui","year":"2022","unstructured":"Cui Y, Guo L, Mu Q, Kang L, Chen Q, Wu Q, He Y, Tang M (2022) Analysis of risk factors for chloral hydrate sedative failure with initial dose in pediatric patients: a retrospective analysis. Paediatr Drugs 24(4):403\u2013412","journal-title":"Paediatr Drugs"},{"issue":"6","key":"5240_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/PEC.0000000000000143","volume":"30","author":"JR Grunwell","year":"2014","unstructured":"Grunwell JR, McCracken C, Fortenberry J, Stockwell J, Kamat P (2014) Risk factors leading to failed procedural sedation in children outside the operating room. Pediatr Emerg Care 30(6):381\u2013387","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"5240_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/pan.13529","volume":"29","author":"J Liu","year":"2019","unstructured":"Liu J, Du M, Liu L, Cao F, Xu Y (2019) Sedation effects of intranasal dexmedetomidine combined with ketamine and risk factors for sedation failure in young children during transthoracic echocardiography. Paediatr Anaesth 29(1):77\u201384","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"5240_CR30","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1460-9592.2010.03299.x","volume":"20","author":"KP Mason","year":"2010","unstructured":"Mason KP, Zurakowski D, Zgleszewski S, Prescilla R, Fontaine PJ, Dinardo JA (2010) Incidence and predictors of hypertension during high-dose dexmedetomidine sedation for pediatric MRI. Paediatr Anaesth 20(6):516\u2013523","journal-title":"Paediatr Anaesth"},{"key":"5240_CR31","volume":"2015","author":"SS Ahmed","year":"2015","unstructured":"Ahmed SS, Unland T, Slaven JE, Nitu ME (2015) High dose dexmedetomidine: effective as a sole agent sedation for children undergoing MRI. Int J Pediatr 2015:397372","journal-title":"Int J Pediatr"},{"key":"5240_CR32","unstructured":"Hazinski MF (2013) Children are different. Nursing care of the critically ill child. 3rd ed. St Louis, Mo: Mosby, copyright Elsevier, pp. 10\u201318"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05240-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-05240-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05240-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T05:12:37Z","timestamp":1707455557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-05240-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["5240"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-05240-5","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local research ethics committee granted ethical approval (2022-IBR-0289-P-01) and the study has been registered in the Chinese Clinical Trial Registry (ChiCTR2300067578) on January 22, 2023. All procedures were conducted in accordance with the ethical standards set forth by the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards, ensuring compliance and protection of participant rights and confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This is an observational study. The local research ethics committee has confirmed that informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}